Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: Analysis from the National Cancer Data Base

Annals of Surgical Oncology

Volumn 19, Issue 9, 2012, Pages 2814-2821

  Hyngstrom, John R ^a   Hu, Chung Yuan ^a   Xing, Yan ^a   You, Y Nancy ^a   Feig, Barry W ^a   Skibber, John M ^a   Rodriguez Bigas, Miguel A ^a   Cormier, Janice N ^a   Chang, George J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CLINICAL FEATURE; COLON; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HEMICOLECTOMY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCINOUS COLORECTAL ADENOCARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOPHYSIOLOGY; RECTUM; SIGNET RING CARCINOMA; SIGNET RING COLORECTAL ADENOCARCINOM; SIGNET RING COLORECTAL ADENOCARCINOMA; SURVIVAL RATE; TOTAL COLON RESECTION; TREATMENT INDICATION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RECTAL NEOPLASMS; SEX FACTORS; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84867398441     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2321-7     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Kang H, O'Connell JB, Maggard MA, et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 2005;48:1161-8.
3. Borger ME, Gosens MJ, Jeuken JW, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212:278-86.
4. Messerini L, Palomba A, Zampi G. Primary signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 1995;38:1189-92.
5. Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer. 1976;37:1891-900.
6. Parham D. Colloid carcinoma. Ann Surg. 1923;77:90-105.
7. Mizushima T, Nomura M, Fujii M, et al. Primary colorectal signet-ring cell carcinoma: clinicopathological features and postoperative survival. Surg Today. 2010;40:234-8.
8. Pande R, Sunga A, Levea C, et al. Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum. 2008;51:50-5.
9. Song W, Wu SJ, He YL, et al. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl). 2009;122:1486-91.
10. Sung CO, Seo JW, Kim KM, et al. Clinical significance of signetring cells in colorectal mucinous adenocarcinoma. Mod Pathol. 2008;21:1533-41.
11. Berg JW, Godwin JD 2nd. The epidemiologic pathology of carcinomas of the large bowel. J Surg Oncol. 1974;6:381-400.
12. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138:2073-87.
13. Connelly JH, Robey-Cafferty SS, Cleary KR. Mucinous carcinomas of the colon and rectum. An analysis of 62 stage B and C lesions. Arch Pathol Lab Med. 1991;115:1022-5.
14. Consorti F, Lorenzotti A, Midiri G, Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol. 2000;73:70-4.
15. Green JB, Timmcke AE, Mitchell WT, et al. Mucinous carcinoma-just another colon cancer? Dis Colon Rectum. 1993;36:49-54.
16. Kanemitsu Y, Kato T, Hirai T, et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum. 2003;46:160-7.
17. Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol. 2000;75:103-7.
18. Purdie CA, Piris J. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathology. 2000;36:121-6.
19. Sasaki O, Atkin WS, Jass JR. Mucinous carcinoma of the rectum. Histopathology. 1987;11:259-72.
20. Xie L, Villeneuve PJ, Shaw A. Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int J Oncol. 2009;34:1109-15.
21. Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683-90.
22. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101-21.
23. Hoel DG, Ron E, Carter R, Mabuchi K. Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst. 1993;85:1063-8.
24. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23:51-64.
25. Shin US, Yu CS, Kim JH, et al. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. Ann Surg Oncol. 2011;18:2232-9.
26. Gunderson LL, Jessup JM, Sargent DJ, et al. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28:264-71.
27. Shia J, Guillem JG, Moore HG, et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol. 2004;28:215-23.
28. Smith KD, Tan D, Das P, et al. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg. 2010;251:261-4.